BIM-23027
78981-49-4
|
BIM-26226
136207-23-3
|
Bim BH3, Peptide IV
721885-31-0
|
BIM-23190
182153-96-4
|
Bim BH3, Peptide IV
2088247-34-9
|
BIM-23627 trifluoroacetate salt
429619-37-4
|
DOTA-BIM-23014:DOTA-Lanreotide
213187-44-1
|
BIM-46050
201487-52-7
|
BIM-23127
179188-73-9
|
HCl-BIm
18227-18-4
|
N-cyclopropyl-1-[3-(trifluoromethyl)pyridin-2-yl]piperidine-3-carboxamide
2877680-67-4
|
N-cyclopropyl-1-[2-(trifluoromethyl)pyridin-4-yl]piperidine-3-carboxamide
2877686-08-1
|
N-tert-butyl-1-(5-methyl-1,3-thiazol-2-yl)piperidine-3-carboxamide
2877647-39-5
|
N-tert-butyl-1-(3-chloro-5-cyanopyridin-2-yl)piperidine-3-carboxamide
2877647-69-1
|
4-Piperidinecarboxamide, 2-methyl-6-oxo-N-[2-(4-phenyl-1-piperazinyl)propyl]-
2195830-00-1
|
(3I(2),9I(3/4),16I(2))-3-Hydroxy-21-iodo-2a(2)-methyl-5a(2)H-pregn-4-eno[17,16-d]oxazol-20-one
1185731-47-8
|
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tris(2-methylheptyl) ester
2244913-12-8
|
1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-1-[2-(methylthio)phenyl]-5-phenyl-
1264047-00-8
|
Iron, (L-ascorbato)(dihydrogen phosphato)-, cyclic 2a(2),3a(2)-ester with adenosine
19040-05-2
|
(E)-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]but-3-en-2-one
2070868-49-2
|
